Zhang Zhuohua visited private enterprises in Changsha: Give full play to the advantages of the traditional Chinese medicine industry, and help the medical weapon Hunan Army to become bigger and stronger

Author:CPPCC Time:2022.07.07

Today (July 7), Zhang Zhuohua, vice chairman of the Provincial Political Consultative Conference, led the CPPCC CPPCC Cultural, Education and Health Committee, the Provincial Administration of Traditional Chinese Medicine, the Provincial Traditional Chinese Medicine Administration, the Provincial Health and Health Commission and some members to carry out some private enterprises in Changsha to "stabilize the economy, the economy, the economy, Investigation of Huimin Sheng and Safety ", understand the production and operation status of the enterprise and the implementation of the rescue policies of the enterprise, and listen to opinions and suggestions.

The "Chinese Lao Zee" Jiuzhitang began in 1650 AD and has now developed into a modern large -scale pharmaceutical company that integrates production, sales, scientific research, and health management. Zhang Zhuohua deeply learned about the advantages and sales of Jiuzhitang.

Sannuo Biosensor Co., Ltd. is a listed company in Changsha High -tech Zone. After 20 years of development, it has grown into a global enterprise. At present, there are 7 R & D and production bases around the world, and products exported to 135 countries around the world.

Zhang Zhuohua experienced products such as Sannuo Bio -developed hemuroic acid detector, advanced glycosylation ending product fluorescence detector, etc., which continued to increase the awareness of enterprise innovation and continued to be highly recognized by scientific research funds.

"The main purpose of our investigation is to understand whether the company encountered problems and difficulties in the development process." Zhang Zhuohua asked at the symposium. "Since the epidemic, the price of the company's product materials has increased significantly, and the price of Chinese medicinal materials has fluctuated frequently. It has undergone a lot of pressure on the quality control and cost control of the enterprise. The resources such as medical insurance are inclined, and the cultivation of traditional Chinese medicine talents will be strengthened.

"The company's dynamic blood glucose detection system (CGM) is planned to be put into production by the end of the year, but its production line is customized in the United States. It is hoped that the speed of import customs clearance can be more convenient and provide guarantee for product production." Products, set up green channels for price approval, accelerate corporate innovation and transformation, and effectively reduce corporate innovation risks.

Zhang Zhuohua coordinated the implementation of relevant departments on -site issues raised by the enterprise. He said that in recent years, the Hunan pharmaceutical regulatory department has promoted the reform of the administrative approval system, the medical device review and approval have accelerated, and the forefront of the country has created a good business environment for the development of Hunan pharmaceutical and medical device enterprises. Enterprises develop in Hunan. For the suggestions made by enterprises, he stated that he would reflect the provincial party committee, provincial government, and national level, helping enterprises to relieve difficulties, and promote the development of the medical and medical industry in our province.